Ameriprise’s Rock Creek Pharmaceuticals RCPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-13,106
Closed – – 3823
2016
Q4
$0 Sell
13,106
-29,440
-69% – ﹤0.01% 4036
2016
Q3
$0 Sell
42,546
-50,200
-54% – ﹤0.01% 3939
2016
Q2
$1K Sell
92,746
-18,140
-16% -$196 ﹤0.01% 3759
2016
Q1
$40K Sell
110,886
-55,428
-33% -$20K ﹤0.01% 3685
2015
Q4
$121K Sell
166,314
-16,780
-9% -$14.9K ﹤0.01% 3722
2015
Q3
$150K Sell
183,094
-54,757
-23% -$61K ﹤0.01% 3687
2015
Q2
$362K Buy
237,851
+49,654
+26% +$118K ﹤0.01% 3576
2015
Q1
$460K Buy
+188,197
New +$741K ﹤0.01% 3237
2014
Q4
– Sell
-80
Closed -$1K – 5122
2014
Q3
$1K Hold
80
– – ﹤0.01% 5687
2014
Q2
$1K Buy
+80
New +$1.39K ﹤0.01% 5478

Ameriprise's RCPI Position: Q1 2017 in Review

Ameriprise sold out of Rock Creek Pharmaceuticals (RCPI) in Q1 2017, closing a stake of 13,106 shares.

Ameriprise first reported a position in RCPI in Q2 2014 and held it in 10 quarters. The position peaked at $460K in Q1 2015. 0 funds tracked by Wall St. Rank hold RCPI as of Q1 2017.

  • Ameriprise reported no remaining Rock Creek Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Ameriprise sold 13,106 Rock Creek Pharmaceuticals shares in Q1 2017.
  • Ameriprise first reported a position in Rock Creek Pharmaceuticals in Q2 2014 and held it in 10 quarters.
  • Ameriprise's Rock Creek Pharmaceuticals position peaked at $460K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Rock Creek Pharmaceuticals as of Q1 2017.

Based on Ameriprise's 13F filing for Q1 2017, filed 5 May 2017.